BioSpace News Archive

Lantern Pharma Inc., a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence platform to transform oncology drug discovery and development, announced that an interview with CEO Panna Sharma will air on The RedChip Money Report® on Bloomberg TV in the US on Saturday, March 13, at 7 p.m. local time.

Ocugen, Inc. (“Ocugen”) (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, today announced that it will host a conference call to discuss its 2020 financial results and provide a business update at 8:30 a.m. ET on Thursday, March 18, 2021.

Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage biopharmaceutical company that is genetically engineering red blood cells to create an entirely new class of cellular medicines called Red Cell Therapeutics™, today announced that the Company plans to issue a pre-market press release and conduct a webcast on Monday, March 15, 2021

Deborah Birx, M.D., a physician, scientific researcher and former White House Coronavirus Coordinator, will join Dallas-based ActivePure Technologies as chief medical and scientific advisor, the company’s CEO, Joseph Urso, announced today.

Quantum Leap Healthcare Collaborative (QLHC), the sponsor of the I-SPY COVID Trial, announced that apremilast (Otezla), made by Amgen, has been dropped for futility